Publication Cover
The Women's Oncology Review
The Journal of Interdisciplinary Current Awareness
Volume 6, 2007 - Issue 1-2
3
Views
0
CrossRef citations to date
0
Altmetric
Commentary

High dose ifosfamide plus doxorubicin for advanced or metastatic gynecologic sarcomas

S. Leyvraz, M. Zweifel, G. Jundt, A. Lissoni, T. Cerny, C. Sessa, M. Fey, D. Dietrich, H.P. Honegger. Long-term results of a multicenter SAKK trial on high-dose ifosfamide and doxorubicin in advanced or metastatic gynecologic sarcomas. Ann Oncol 2006;17:646–651.

Pages 109-110 | Published online: 04 Dec 2011

References

  • Omura GA, Major FJ, Blessing JA, et al. A randomized study of adriamycin with and without dimethyl triazeno-limidazole carboxamide in advanced uterine sarcomas. Cancer 1983;52:626–632
  • Sutton GP, Blessing JA, Barrett FJ, McGehee R. Phase II trial of ifosfamide and mesna in leiomyosarcoma of the uterus: a Gynecologic Oncology Group study. Am J Obstet Gynecol 1992;166:556–559
  • Sutton G, Blessing JA, Ball H. Phase II trial of paclitaxel in leiomyosarcoma of the uterus: a Gynecologic Oncology Group study. Gynecol Oncol 1999;74:346–349
  • Hensley, ML, Maki R, Venkatraman E, Geller G, Lovegren M, Aghajanian C, Sabbatini P, Tong W, Barakat R, Spriggs D. Gemcitabine and docetaxel in patients with unresect-able leiomyosarcoma: results of a phase II trial. J Clin Oncol 2002;20:2824–2831

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.